Endothelin-receptor antagonism: the future is bright.
Dhaun
Neeraj
N
Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK. bean.dhaun@ed.ac.uk
Webb
David J
DJ
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan